In vitro functional characterization of 37 CYP2C9 allelic isoforms found in Chinese Han population

被引:53
作者
Dai, Da-peng [1 ,2 ]
Wang, Yu-han [3 ]
Wang, Shuang-hu [4 ]
Geng, Pei-wu [4 ]
Hu, Li-ming [4 ]
Hu, Guo-xin [4 ]
Cai, Jian-ping [1 ,2 ]
机构
[1] Beijing Hosp, Key Lab Geriatr, Beijing 100730, Peoples R China
[2] Beijing Inst Geriatr, Minist Hlth, Beijing 100730, Peoples R China
[3] Shandong Univ, Coll Med, Jinan 250012, Peoples R China
[4] Wenzhou Med Univ, Dept Pharmacol, Wenzhou 325035, Peoples R China
关键词
CYP2C9; allelic variants; drug metabolism; tolbutamide; Chinese Han population; DEFECTIVE ALLELES; 2C9; GENE; VARIANTS; CYTOCHROME-P450; POLYMORPHISM; JAPANESE; METABOLISM; ASIANS;
D O I
10.1038/aps.2013.123
中图分类号
O6 [化学];
学科分类号
0703 ;
摘要
Aim: Cytochrome P450 2C9 (CYP2C9) is a polymorphic enzyme that is responsible for the metabolism of approximately 15% of clinically important drugs. The aim of this study was to assess the catalytic characteristics of 37 CYP2C9 allelic isoforms found in Chinese Han population on the metabolism of tolbutamide in vitro. Methods: The wild-type and 36 CYP2C9 variants were expressed in sf21 insect cells using a baculovirus-mediated expression system. Then the insect microsomes were prepared for assessing the metabolic characteristics of each variant toward the CYP2C9-specific drug substrate tolbutamide. Results: Of 36 allelic variants tested, the intrinsic clearance values of 2 allelic isoforms (CYP2C9.36 and CYP2C9.51) were much higher than the wild-type CYP2C9.1 protein, 3 allelic isoforms (CYP2C9.11, CYP2C9.56 and N418T) exhibited similar intrinsic clearance values as the wild-type enzyme, whereas the other 31 variants showed significantly reduced intrinsic clearance values, ranging from 0.08% to 66.88%, for tolbutamide. Conclusion: Our study provides the most comprehensive data concerning the enzymatic activity of the CYP2C9 variants that are present in the Chinese Han population, and our data suggest that most of the carriers of these alleles might be paid more attention when using CYP2C9 mediated drugs clinically.
引用
收藏
页码:1449 / 1456
页数:8
相关论文
共 50 条
[31]   Influence of CYP2C9 and CYP2C19 genetic polymorphisms on pharmacokinetics and pharmacodynamics of gliclazide in healthy Chinese Han volunteers [J].
Shao, H. ;
Ren, X. M. ;
Liu, N. F. ;
Chen, G. M. ;
Li, W. L. ;
Zhai, Z. H. ;
Wang, D. W. .
JOURNAL OF CLINICAL PHARMACY AND THERAPEUTICS, 2010, 35 (03) :351-360
[32]   An identification and functional evaluation of a novel CYP2C9 variant CYP2C9*62 [J].
Chen, Hao ;
Dai, Da-Peng ;
Zhou, Shan ;
Liu, Jian ;
Wang, Shuang-Hu ;
Wu, Hua-Lan ;
Zhou, Quan ;
Geng, Pei-Wu ;
Chong, Jia ;
Lu, You ;
Cai, Jian-Ping ;
Yang, Jie-Fu .
CHEMICO-BIOLOGICAL INTERACTIONS, 2020, 327
[33]   CYP2C9 polymorphism analysis in Han Chinese populations: building the largest allele frequency database [J].
Dai, D-P ;
Xu, R-A ;
Hu, L-M ;
Wang, S-H ;
Geng, P-W ;
Yang, J-F ;
Yang, L-P ;
Qian, J-C ;
Wang, Z-S ;
Zhu, G-H ;
Zhang, X-H ;
Ge, R-S ;
Hu, G-X ;
Cai, J-P .
PHARMACOGENOMICS JOURNAL, 2014, 14 (01) :85-92
[34]   Systematic polymorphism analysis of the CYP2C9 gene in Chinese Han and Tibetan populations [J].
Yue-Wen Wang ;
Xiao-Hong Meng ;
Wei Yan ;
Xiao-Qing Zhang ;
Jin Yang .
Genes & Genomics, 2012, 34 :291-297
[35]   CYP2C9 polymorphism studies in the Saudi population [J].
Saour, Jalal N. ;
Shereen, Atia W. ;
Saour, Basil J. ;
Mammo, Layla A. .
SAUDI MEDICAL JOURNAL, 2011, 32 (04) :347-352
[36]   In Vitro Functional Assessment of 22 Newly Identified CYP2D6 Allelic Variants in the Chinese Population [J].
Dai, Da-Peng ;
Geng, Pei-Wu ;
Wang, Shuang-Hu ;
Cai, Jie ;
Hu, Li-Ming ;
Nie, Jing-Jing ;
Hu, Ji-Hong ;
Hu, Guo-Xin ;
Cai, Jian-Ping .
BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY, 2015, 117 (01) :39-43
[37]   In vitro assessment of 39 CYP2C9 variants found in the Chinese population on the metabolism of the model substrate fluoxetine and a summary of their effects on other substrates [J].
Ji, Y. ;
Chen, S. ;
Zhao, L. ;
Pan, P. ;
Wang, L. ;
Cai, J. ;
Dai, D. ;
Hu, G. ;
Cai, J. P. ;
Huang, H. .
JOURNAL OF CLINICAL PHARMACY AND THERAPEUTICS, 2015, 40 (03) :320-327
[38]   Identification of a novel variant CYP2C9 allele in Chinese [J].
Si, DY ;
Guo, YJ ;
Zhang, YF ;
Yang, L ;
Zhou, H ;
Zhong, DF .
PHARMACOGENETICS, 2004, 14 (07) :465-469
[39]   Substrate-Dependent Functional Alterations of Seven CYP2C9 Variants Found in Japanese Subjects [J].
Maekawa, Keiko ;
Harakawa, Noriko ;
Sugiyama, Emiko ;
Tohkin, Masahiro ;
Kim, Su-Ryang ;
Kaniwa, Nahoko ;
Katori, Noriko ;
Hasegawa, Ryuichi ;
Yasuda, Kazuki ;
Kamide, Kei ;
Miyata, Toshiyuki ;
Saito, Yoshiro ;
Sawada, Jun-ichi .
DRUG METABOLISM AND DISPOSITION, 2009, 37 (09) :1895-1903
[40]   Function of 38 variants CYP2C9 polymorphism on ketamine metabolism in vitro [J].
Zheng, Xiang ;
Fang, Ping ;
Bao, Su-su ;
Lin, Dan ;
Cai, Jian-ping ;
Hu, Guo-xin .
JOURNAL OF PHARMACOLOGICAL SCIENCES, 2017, 135 (01) :8-13